Table 1

Demographic and clinical characteristics of the study population at baseline
Characteristic Intervention group (n=30) Control group (n=30)
Patient information
Age in years Mean [SD]
Parity
Gravidity
Gestational age at first visit in weeks Mean [SD]
Height in cm Mean [SD]
Adherence Score Median [IQR]
Ethnicity
Australian
Arabic
Asian
European
Other
Asthma severity+
Intermittent to Mild
Moderate to Severe
Asthma medication
SABA only
ICS+SABA
ICS/LABA + SABA
FEV1 in litres Mean [SD]
FEV1%predicted Mean [SD]
FEV1/FEV6 Mean [SD]
Co-morbidity
Gestational diabetes
Hypertension in pregnancy
Anxiety/depression
Other
Smokers
Health Care Concession Card holders

ICS – inhaled corticosteroid, LABA- Long acting beta agonist, SABA – short acting beta agonist.

+Asthma severity classified by National Asthma Handbook [28].

Values are given as number (percentages) unless specified.

Lim et al.

Lim et al. BMC Public Health 2012 12:1094   doi:10.1186/1471-2458-12-1094

Open Data